These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20122108)

  • 1. Gene therapy oversight: lessons for nanobiotechnology.
    Wolf SM; Gupta R; Kohlhepp P
    J Law Med Ethics; 2009; 37(4):659-84. PubMed ID: 20122108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: Who's afraid of the RAC? Lessons from the oversight of controversial science.
    Kahn JP
    J Law Med Ethics; 2009; 37(4):685-7. PubMed ID: 20122109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.
    Paradise J; Wolf SM; Kuzma J; Kuzhabekova A; Tisdale AW; Kokkoli E; Ramachandran G
    J Law Med Ethics; 2009; 37(4):688-705. PubMed ID: 20122110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating oversight of human drugs and medical devices: a case study of the FDA and implications for nanobiotechnology.
    Paradise J; Tisdale AW; Hall RF; Kokkoli E
    J Law Med Ethics; 2009; 37(4):598-624. PubMed ID: 20122103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.
    Kuzma J; Najmaie P; Larson J
    J Law Med Ethics; 2009; 37(4):546-86. PubMed ID: 20122100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Next Phase of Human Gene-Therapy Oversight.
    Collins FS; Gottlieb S
    N Engl J Med; 2018 Oct; 379(15):1393-1395. PubMed ID: 30110242
    [No Abstract]   [Full Text] [Related]  

  • 8. RAC oversight of gene transfer research: a model worth extending?
    King NM
    J Law Med Ethics; 2002; 30(3):381-9. PubMed ID: 12497698
    [No Abstract]   [Full Text] [Related]  

  • 9. Supervising gene therapy, openly.
    Lancet; 1997 Jul; 350(9071):79. PubMed ID: 9228953
    [No Abstract]   [Full Text] [Related]  

  • 10. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant DNA research: notice of intent to propose amendments to the NIH Guidelines for research involving recombinant DNA molecules (NIH Guidelines) regarding enhanced mechanisms for NIH oversight of recombinant DNA activities.
    U.S. National Institutes of Health
    Fed Regist; 1996 Jul; 61(131):35774-7. PubMed ID: 11654428
    [No Abstract]   [Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAC's review of gene therapy: it's time to move on.
    Post LE
    Hum Gene Ther; 1994 Nov; 5(11):1311-2; discussion 1313-4. PubMed ID: 7893802
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant DNA research: actions under the guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1995 Apr; 60(81):20726-37. PubMed ID: 11656763
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant DNA research: proposed actions under the guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1996 Nov; 61(227):59726-42. PubMed ID: 11645326
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular medicine. One less hoop for gene therapy.
    Marshall E
    Science; 1994 Jul; 265(5172):599. PubMed ID: 8036507
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of human gene therapy.
    Chase GA; DeLeon PA; Dronamraju KR; Erickson RP; Glorioso JC; Hirschhorn R; Lysaught MT; McGraw KM; Meyers AS; Miller AD
    Science; 1995 Jul; 269(5220):14-5. PubMed ID: 7604272
    [No Abstract]   [Full Text] [Related]  

  • 18. Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future.
    Walters L; Cook-Deegan RM; Adashi EY
    CRISPR J; 2021 Aug; 4(4):469-476. PubMed ID: 34406046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH.
    Friedmann T; Noguchi P; Mickelson C
    Curr Opin Biotechnol; 2001 Jun; 12(3):304-7. PubMed ID: 11404110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human gene therapy: a biopolitical overview and analysis.
    Carmen IH
    Hum Gene Ther; 1993 Apr; 4(2):187-93. PubMed ID: 8494928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.